Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-044412

Chief Executive Officer sold 7,800 shares at an average $38.00 ($296,432)

From the SEC's structured data for this filing

Trades in this filing

Ciechanover Isaac E. · Chief Executive Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2018-07-26 Sale : show line 1 in the form −3,800 $39.02 $148,276 93,878 I
2018-07-26 Sale : show line 2 in the form −100 $39.45 $3,945 93,778 I
2018-07-27 Sale : show line 3 in the form −2,200 $36.55 $80,410 91,578 I
2018-07-27 Sale : show line 4 in the form −1,700 $37.53 $63,801 89,878 I
Open-market sales · 7,800 sh · avg $38.00 · $296,432
Loading xslF345X03/doc4.xml…